Instead, our data showed strong association between tumor subtypes and pCR, consistent with multiple other prior studies [46–52], with ER−/HER2+ tumors exhibiting highest pCR rates, followed by triple negative, ER+/HER2+ and ER+/HER2−. This evidence concerns the gene ERBB2 and neoplasm.